Pharmacotherapy of tension-type headache (TTH)

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Tension-type headache (TTH) is a highly prevalent condition, yet it requires less medical attention than migraine, mostly because the pain and disability burden are milder. Methods: Proper diagnosis is a paramount step in therapeutic adequacy. It comes from careful history, thorough physical examination and use of ancillary investigations when appropriate to rule out underlying causes of secondary headaches that could mimic TTH, as there is no biological marker for the condition. Results: Research in TTH is insufficient. Thus, pathophysiologic understanding and therapeutic innovations are lagging. In that context, the clinicians should not be surprised by the paucity of pharmacotherapeutic options. Conclusion: In this article, we review the existing literature on medications and make practical recommendations based on the evidence of their efficacy. We review both abortive and prophylactic medications (such as tricyclic antidepressants and non-steroidal anti-inflammatory drugs, respectively). Both are used for chronic TTH and abortive medications only for infrequent episodic TTH (ETTH). As far as frequent ETTH, abortive medications are used and prophylactic medications often but not systematically. We comment and advise on general therapeutic principles of TTH management.

Original languageEnglish (US)
Pages (from-to)1261-1271
Number of pages11
JournalExpert Opinion on Pharmacotherapy
Volume10
Issue number8
DOIs
StatePublished - Jun 2009

Fingerprint

Tension-Type Headache
Drug Therapy
Headache Disorders
Tricyclic Antidepressive Agents
Migraine Disorders
Physical Examination
Headache
Anti-Inflammatory Agents
Therapeutics
Biomarkers
History
Pain
Research
Pharmaceutical Preparations

Keywords

  • Headache
  • Pharmacotherapy
  • Tension-type
  • Treatment

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Pharmacotherapy of tension-type headache (TTH). / Lenaerts, Marc E.

In: Expert Opinion on Pharmacotherapy, Vol. 10, No. 8, 06.2009, p. 1261-1271.

Research output: Contribution to journalArticle

@article{7d1a8e4d40ab43598bc7bb5273935b0b,
title = "Pharmacotherapy of tension-type headache (TTH)",
abstract = "Background: Tension-type headache (TTH) is a highly prevalent condition, yet it requires less medical attention than migraine, mostly because the pain and disability burden are milder. Methods: Proper diagnosis is a paramount step in therapeutic adequacy. It comes from careful history, thorough physical examination and use of ancillary investigations when appropriate to rule out underlying causes of secondary headaches that could mimic TTH, as there is no biological marker for the condition. Results: Research in TTH is insufficient. Thus, pathophysiologic understanding and therapeutic innovations are lagging. In that context, the clinicians should not be surprised by the paucity of pharmacotherapeutic options. Conclusion: In this article, we review the existing literature on medications and make practical recommendations based on the evidence of their efficacy. We review both abortive and prophylactic medications (such as tricyclic antidepressants and non-steroidal anti-inflammatory drugs, respectively). Both are used for chronic TTH and abortive medications only for infrequent episodic TTH (ETTH). As far as frequent ETTH, abortive medications are used and prophylactic medications often but not systematically. We comment and advise on general therapeutic principles of TTH management.",
keywords = "Headache, Pharmacotherapy, Tension-type, Treatment",
author = "Lenaerts, {Marc E}",
year = "2009",
month = "6",
doi = "10.1517/14656560902942046",
language = "English (US)",
volume = "10",
pages = "1261--1271",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Pharmacotherapy of tension-type headache (TTH)

AU - Lenaerts, Marc E

PY - 2009/6

Y1 - 2009/6

N2 - Background: Tension-type headache (TTH) is a highly prevalent condition, yet it requires less medical attention than migraine, mostly because the pain and disability burden are milder. Methods: Proper diagnosis is a paramount step in therapeutic adequacy. It comes from careful history, thorough physical examination and use of ancillary investigations when appropriate to rule out underlying causes of secondary headaches that could mimic TTH, as there is no biological marker for the condition. Results: Research in TTH is insufficient. Thus, pathophysiologic understanding and therapeutic innovations are lagging. In that context, the clinicians should not be surprised by the paucity of pharmacotherapeutic options. Conclusion: In this article, we review the existing literature on medications and make practical recommendations based on the evidence of their efficacy. We review both abortive and prophylactic medications (such as tricyclic antidepressants and non-steroidal anti-inflammatory drugs, respectively). Both are used for chronic TTH and abortive medications only for infrequent episodic TTH (ETTH). As far as frequent ETTH, abortive medications are used and prophylactic medications often but not systematically. We comment and advise on general therapeutic principles of TTH management.

AB - Background: Tension-type headache (TTH) is a highly prevalent condition, yet it requires less medical attention than migraine, mostly because the pain and disability burden are milder. Methods: Proper diagnosis is a paramount step in therapeutic adequacy. It comes from careful history, thorough physical examination and use of ancillary investigations when appropriate to rule out underlying causes of secondary headaches that could mimic TTH, as there is no biological marker for the condition. Results: Research in TTH is insufficient. Thus, pathophysiologic understanding and therapeutic innovations are lagging. In that context, the clinicians should not be surprised by the paucity of pharmacotherapeutic options. Conclusion: In this article, we review the existing literature on medications and make practical recommendations based on the evidence of their efficacy. We review both abortive and prophylactic medications (such as tricyclic antidepressants and non-steroidal anti-inflammatory drugs, respectively). Both are used for chronic TTH and abortive medications only for infrequent episodic TTH (ETTH). As far as frequent ETTH, abortive medications are used and prophylactic medications often but not systematically. We comment and advise on general therapeutic principles of TTH management.

KW - Headache

KW - Pharmacotherapy

KW - Tension-type

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=67649687503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649687503&partnerID=8YFLogxK

U2 - 10.1517/14656560902942046

DO - 10.1517/14656560902942046

M3 - Article

VL - 10

SP - 1261

EP - 1271

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 8

ER -